###begin article-title 0
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 157 163 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
MeCP2, methyl-CpG-binding protein 2, binds to methylated cytosines at CpG dinucleotides, as well as to unmethylated DNA, and affects chromatin condensation. MECP2 mutations in females lead to Rett syndrome, a neurological disorder characterized by developmental stagnation and regression, loss of purposeful hand movements and speech, stereotypic hand movements, deceleration of brain growth, autonomic dysfunction and seizures. Most mutations occur de novo during spermatogenesis. Located at Xq28, MECP2 is subject to X inactivation, and affected females are mosaic. Rare hemizygous males suffer from a severe congenital encephalopathy.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 430 438 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 253 258 <span type="species:ncbi:10090">mouse</span>
To identify the pathways mis-regulated by MeCP2 deficiency, microarray-based global gene expression studies were carried out in cerebellum of Mecp2 mutant mice. We compared transcript levels in mutant/wildtype male sibs of two different MeCP2-deficient mouse models at 2, 4 and 8 weeks of age. Increased transcript levels were evaluated by real-time quantitative RT-PCR. Chromatin immunoprecipitation assays were used to document in vivo MeCP2 binding to promoter regions of candidate target genes.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 274 282 274 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Jae</sup>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 328 337 328 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Bird</sup>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1</italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln</italic>
###xml 709 718 709 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2/Meg3</italic>
###xml 883 891 883 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 928 939 928 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1, Reln</italic>
###xml 945 949 945 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
Of several hundred genes with altered expression levels in the mutants, twice as many were increased than decreased, and only 27 were differentially expressed at more than one time point. The number of misregulated genes was 30% lower in mice with the exon 3 deletion (Mecp2tm1.1Jae) than in mice with the larger deletion (Mecp2tm1.1Bird). Between the mutants, few genes overlapped at each time point. Real-time quantitative RT-PCR assays validated increased transcript levels for four genes: Irak1, interleukin-1 receptor-associated kinase 1; Fxyd1, phospholemman, associated with Na, K-ATPase;Reln, encoding an extracellular signaling molecule essential for neuronal lamination and synaptic plasticity; and Gtl2/Meg3, an imprinted maternally expressed non-translated RNA that serves as a host gene for C/D box snoRNAs and microRNAs. Chromatin immunoprecipitation assays documented in vivo MeCP2 binding to promoter regions of Fxyd1, Reln, and Gtl2.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 137 155 137 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1, Fxyd1, Reln</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
Transcriptional profiling of cerebellum failed to detect significant global changes in Mecp2-mutant mice. Increased transcript levels of Irak1, Fxyd1, Reln, and Gtl2 may contribute to the neuronal dysfunction in MeCP2-deficient mice and individuals with Rett syndrome. Our data provide testable hypotheses for future studies of the regulatory or signaling pathways that these genes act on.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 882 883 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 884 885 884 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 888 896 888 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 994 1017 994 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FMR1, H19, CCNA1, BRCA1</italic>
###xml 1044 1045 1044 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1046 1047 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1100 1101 1100 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 1205 1206 1205 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1207 1208 1207 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 599 604 <span type="species:ncbi:10090">mouse</span>
DNA methylation is one of several strategies cells employ to regulate gene expression. In mammals, cytosine methylation at CpG dinucleotides is essential for tissue-specific gene expression, X-chromosome inactivation, genomic imprinting and silencing of transposable elements. The methylation signal is interpreted by a family of proteins that bind to methylated CpGs and recruit transcriptional repressor complexes. MeCP2, methyl-CpG-binding protein 2, was the first identified member of this family [1]. MeCP2 is an abundant nuclear protein that binds preferentially to heterochromatin regions on mouse chromosomes [1]. MeCP2 has a methyl-CpG-binding domain (MBD) that binds to methylated CpG dinucleotides adjacent to AT sequences [2]. Chromatin immunoprecipitation (ChIP) with anti-MeCP2 antibodies precipitated a large number of repetitive sequences as well as gene sequences [3,4]. In vitro, MeCP2 binds to promoters and represses transcription of diverse disease-related loci, including FMR1, H19, CCNA1, BRCA1, and several other genes [5-8]. Additional functions of MeCP2 may be unrelated to mCpG binding: chromatin compaction, chromatin looping, alternative splicing, and nuclear reorganization [4,9-12].
###end p 11
###begin p 12
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 425 431 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 651 657 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
MECP2 mutations are identified in ~ 90% of cases of classical Rett syndrome (RTT) [13-15]. RTT (OMIM 312750) is a neurological disorder characterized by apparently normal development for the first few months followed by developmental stagnation and regression, loss of purposeful hand movements and speech, truncal ataxia, stereotypic hand movements, deceleration of brain growth, autonomic dysfunction and seizures [16-19]. MECP2 is located at Xq28 and is subject to X inactivation. The classical RTT phenotype is manifest in heterozygous females that are mosaics for cells with either normal or mutant/absent MeCP2 protein. Males with a deleterious MECP2 mutation have no functional MeCP2 protein. Although apparently normal at birth, they display stagnant postnatal development, irregular respiration, central hypoxia and early death [20]. Currently, there is no effective therapy to prevent the developmental regression, autonomous nervous system dysfunction and loss of communication skills in RTT individuals. Gaining more information about MeCP2's functions and identifying the regulatory circuits that are disrupted by MeCP2 deficiency are essential steps for understanding the pathophysiology of RTT.
###end p 12
###begin p 13
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
Originally, it was hypothesized that MeCP2 is a master regulatory protein that prevents inappropriate expression of a potentially large set of genes, and that in the absence of MeCP2, the expression of many genes would be altered. This hypothesis was not confirmed by microarray-based global expression studies. The numbers of mis-regulated genes were quite limited in different tissues from RTT individuals and mouse models with MeCP2 loss-of-function mutations. The lists of mis-regulated genes from different studies are essentially non-overlapping, and the search for specific MeCP2-target genes has turned up very few validated candidates [21-27].
###end p 13
###begin p 14
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 342 348 342 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1018 1023 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 507 512 <span type="species:ncbi:9606">girls</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 1031 1036 <span type="species:ncbi:10090">mouse</span>
We aimed to extend previous global gene expression studies in Mecp2 mutant mouse models by focusing on the cerebellum that was excluded in the previous work of Tudor et al. [23]. Gene expression patterns in the cerebellum are quite distinct from those in other brain regions in many mouse strains studied by Nadler et al. [28]. Expression of Mecp2 increases postnatally and is abundant in the adult cerebellum [29]. The truncal tremor observed in Mecp2-deficient mice [30,31] and the ataxia observed in RTT girls suggest cerebellar pathology. In mutant Mecp2-/Y mice, the cell bodies of cerebellar granule neurons are smaller and more densely packed [30]. Postmortem examination of the cerebella of five RTT females ranging in age from 7-30 years revealed loss of Purkinje cells, atrophy and gliosis [32]. These published data provided the rationale for our study design. To address the possibility of mutation-specific and developmental time-specific changes, we compared expression changes in males of two different Mecp2-mutant mouse strains and at three different postnatal time points.
###end p 14
###begin p 15
###xml 214 232 214 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1, Fxyd1, Reln</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 598 609 598 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1, Reln</italic>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
Consistent with previous studies, we did not detect substantial up-regulation of a discrete set of genes. However, we observed moderately increased transcript levels mostly in 8 wk old mutant mice. For four genes, Irak1, Fxyd1, Reln, and Gtl2, increased transcript levels were validated by real-time quantitative RT-PCR. Attempts at replication of the data on independent samples and in different brain regions yielded variable results. Physical association of these genes with MeCP2 was confirmed by chromatin immunoprecipitation (ChIP) assays that documented MeCP2 binding to promoter regions of Fxyd1, Reln, and Gtl2. This study reports, for the first time, cerebellar expression profiles in Mecp2-mutants and proposes novel MeCP2 target genes that may contribute to the pathophysiology observed in RTT individuals and MeCP2-deficient mice.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse breeding and sample collection
###end title 17
###begin p 18
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 44 52 44 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Jae</sup>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 165 174 165 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Bird</sup>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 912 913 912 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
Females heterozygous for the J-allele (Mecp2tm1.1Jae) [30] were obtained from Rudolf Jaenisch and bred to BALB/cJ males. Females heterozygous for the B-allele (Mecp2tm1.1Bird) [31] were purchased from the Jackson Laboratory and were bred to C57BL/6J male mice. Tail DNA samples were genotyped for Mecp2 and Sry (for sex determination) as described [33]. Sry primers: F: TCCCAGCATGCAAAATACAG; R: TGGTCATGAAACTGCTGCTT. Only male mutant mice and their male wild-type siblings were used, because female heterozygotes are mosaic for MeCP2 deficiency and have variable expressivity of the mutant phenotype. For the microarray experiments and technical validation by qRT-PCR, we studied 23 mutants and 25 wild-type J-allele mice, and 32 mutant and 34 wild-type B-allele mice. For biological validation by qRT-PCR of a new set of samples, we used 20 mutant and 16 wild-type B-allele mice. Animals were euthanized with CO2. Cerebella and forebrains were snap frozen on dry ice. Total RNA was extracted using TRIzol Reagent (Invitrogen) and analyzed on a 1.5% agarose gel in MOPS buffer. RNA was concentrated and purified with YM30 microcon columns (Millipore). The Animal Care Committee of Stanford University approved all experimental procedures.
###end p 18
###begin title 19
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human brain samples
###end title 19
###begin p 20
###xml 416 421 <span type="species:ncbi:9606">human</span>
###xml 500 505 <span type="species:ncbi:9606">Human</span>
Brain samples from RTT individuals, including two hemizygous males with known MECP2 mutations, and non-RTT controls were obtained from the NICHD Brain and Tissue Bank for Developmental Disorders (UMB# 1238, 1420, 1748, 1815, 4516, and 4852) and from the Harvard Brain Tissue Resource Center (#b4160). We extracted total RNA from frozen frontal cortex using RNA Stat 60 (Tel-Test) or TRIzol reagent (Invitrogen). All human materials were obtained and studied under a protocol approved by the Stanford Human Research Protection Program.
###end p 20
###begin title 21
Expression cDNA microarrays
###end title 21
###begin p 22
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
Microarrays were obtained from the Stanford Functional Genomics Facility (SFGF) [34]. These arrays contain 42,000 different transcripts that represent over 26,000 different genes. The transcripts vary in size and are PCR products from the RIKEN FANTHOM clone sets and a consortium of Stanford collaborators. The clone IDs on the cDNA microarrays are available from SFGF. Further information on the clones can be found at SOURCE [35].
###end p 22
###begin title 23
cDNA labelling and microarray hybridization
###end title 23
###begin p 24
###xml 887 889 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
For preparation of reference RNA, we used a pool of 100 cerebella collected from wild-type C57BL/6J and BALB/cJ male mice ranging from P7 to P60 in age. Reference RNA (20 mug) was reverse transcribed using an anchored oligo(dT) primer and labeled with Cy3-dCTP using the CyScribe First-Strand cDNA Labeling Kit (Amersham Biosciences, Catalog # RPN6200). Total RNA (20 mug) from wild-type samples or mutant samples was reverse transcribed and labeled with Cy5-dCTP. Following purification with YM30 microcon tubes, labeled reference cDNA was combined with either labeled wild-type cDNA or labeled mutant cDNA. The combined reactions (reference and wild-type or reference and mutant sample) were applied to a cDNA microarray. Hybridizations were carried out at 65degreesC for 14-16 hr in a waterbath or hybridization oven. Blocking reagents were added according to the Brown Lab protocol [36].
###end p 24
###begin title 25
Microarray data analysis
###end title 25
###begin p 26
###xml 1577 1579 1577 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1871 1873 1871 1873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 2002 2004 2002 2004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 2005 2007 2005 2007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2071 2073 2071 2073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 2104 2106 2104 2106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
Following hybridization, microarrays were washed and immediately scanned with a GenePix 4000B microarray scanner (Axon Instruments/Molecular Devices). Automatic and manual quality analysis of array spots was performed with Genepix Pro 4.0. All microarray data were deposited in the Stanford Microarray Database and normalized by total intensity. The Log (base2) of Red/Green Normalized Ratio (Mean) for each gene was retrieved and averaged only if the spot on the microarray was from the same microtiter plate (LUID - laboratory microtiter well ID). Genes were centered by the mean. Up to five replicate microarrays were evaluated for each mutant allele at each time point. There are 41,000 different spots on each microarray. Some of those spots are not "good" spots, meaning they do not pass the Genepix program filter and/or our manual evaluation. Spots do not pass our filter if the signal is too low, the spot does not have an even distribution of signal, or if there are any other experimental problems that deem the spot of poor quality. Some spots removed for low signal may imply that the gene is not expressed. Regardless of the reason, genes were excluded from our analysis if more than 85% of the spots representing a particular gene are filtered from our data set across replicate microarrays. After filtering, the number of genes that remained in our data set were: J-allele: 2 wk (25,365), 4 wk (30,657), 8 wk (29,774); B-allele: 2 wk (28,939), 4 wk (28,005), 8 wk (26,473). Differentially expressed genes were defined as genes whose expression is consistently (P < 0.05) altered across microarray experiments. Paired t-tests (Microsoft Excel) were performed by comparing the expression of each gene in a mutant sample to expression in its wild-type sibling. The data were analyzed with Microsoft Excel and SAM (Sequence Analysis of Microarrays) software [37]. Microarrays were centered and clustered using hierarchical clustering software available at the Stanford Microarray Database [38,39]. The cDNA microarray data can be accessed online via the SMD [88] or via the EBI ArrayExpress [89].
###end p 26
###begin title 27
Real-time quantitative RT-PCR (qRT-PCR)
###end title 27
###begin p 28
###xml 419 423 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 431 436 427 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; </italic>
###xml 453 459 446 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rps28 </italic>
###xml 463 469 456 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS18 </italic>
###xml 570 575 <span type="species:ncbi:10090">Mouse</span>
Total RNA (2 mug) was treated with 2U DNase I (Ambion) and reverse transcribed with random hexamers as primers and Superscript II (Invitrogen). qRT-PCR was performed using an ABI 5700 (AME Bioscience) instrument. Melting curve analysis was performed for each reaction to ensure a single peak. Amplicons were visualized after electrophoresis on a 2% agarose gel to ensure presence of a single amplicon. Amplification of beta-actin, beta 2-microglobulin, Rps28 and RPS18 transcripts served as RNA controls for relative quantitation (User Bulletin #2, Applied Biosystems). Mouse primers used (5' - 3'):
###end p 28
###begin p 29
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
Mecp2 (F: TGACTTCACGGTAACTGGGAG; R: TTTCACCTGAACACCTTCTGATG),
###end p 29
###begin p 30
###xml 0 11 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
beta-actin (F: TGACCCTGAAGTACCCCATTGA; R: CCATGTCGTCCCAGTTGGTAAC)
###end p 30
###begin p 31
###xml 0 8 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; 2m </italic>
beta 2m (F: ACCCGCCTCACATTGAAATCC; R: CGATCCCAGTAGACGGTCTTG),
###end p 31
###begin p 32
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rps28 </italic>
Rps28 (F: TAGGGTAACCAAAGTGCTGGGCAG; R: GACATTTCGGATGATAGAGCGG),
###end p 32
###begin p 33
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
Irak1 (F: CAGAACCACCACAGATCATCATC; R: GGCTATCCAAGACCCCTTCTTC),
###end p 33
###begin p 34
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
Fxyd1 (F: TCCATTCACCTACGATTACCACA; R: GAATTTGCATCGACATCTCTTGC),
###end p 34
###begin p 35
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
Reln (F: CTGTGTCATACGCCACGAACA; R: GGGGAGGTACAGGATGTGGAT),
###end p 35
###begin p 36
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
Gtl2 (F: GACCCACCTACTGACTGATGAACTG; R: GTGAAGACACAACAGCCTTTCTCC).
###end p 36
###begin p 37
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human primers used (5' - 3'):
###end p 37
###begin p 38
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
FXYD1 (F: AGGGACAATGGCGTCTCTTG; R: CGTAAGTGAACGGGTCGTGTT (NM_005031)
###end p 38
###begin p 39
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS18 </italic>
RPS18 (F: CTTTGCCATCACTGCCATTA; R: ACACGTTCCACCTCATCCTC)
###end p 39
###begin title 40
Chromatin Immunoprecipitation (ChIP)
###end title 40
###begin p 41
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1058 1063 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
We modified a protocol kindly provided by P. Farnham [40]. Brains of 4 wk-old male mice were isolated and minced to small pieces. Cross-linking reactions were performed at room temperature for 15 min in the presence of 1% formaldehyde in PBS. Nuclear extracts were prepared and chromatin was fragmented by sonication to produce DNA fragments of an average length between 500 bp and 1000 bp. After pre-cleaning with salmon sperm DNA/protein A agarose (Upstate), we incubated the nuclear extracts with anti-MeCP2 antibody (Upstate) at 4degreesC overnight. MACs Protein A Micro Beads (Miltenyi Biotec) were added to the reaction to allow the formation of magnetically labeled immune complexes. We purified the bound complexes using a microcolumn following the manufacturer's instructions. After reversal of cross-links and digesting with proteinase K, we isolated DNA fragments with a DNA purification kit (Qiagen). We performed 36 cycles of PCR with primers specific to the first ~ 500-1000 bp of the gene promoter region or to the DMR at the 5' region of the Gtl2 gene.
###end p 41
###begin p 42
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
Primer pairs: Fxyd1 (F: GCATGTCCTGCTGTATGTCG; R: CAGCCAGGGTCAAGAAATGT), Reln (F: AAAGGGAGATTGGGTGACG; R: ACGTGCTTCTGGATGGTTTC), Gtl2 - A (F: TCCAACACGAAATTCTGCAA; R: TGCTGGTCAACATGAACCTC) amplifying nt 94579-94964 and the nested primers Gtl2 - B (F: CGGTCCACTAGGGCTTTTT; R: CCAGGTTTTTAGACCCCAGA) amplifying nt 94645-94775 of AJ320506.
###end p 42
###begin title 43
Results
###end title 43
###begin title 44
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Mecp2-mutant mice differ in phenotype and expression of mutant Mecp2 allele
###end title 44
###begin p 45
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 99 108 99 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Jae </sup>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 507 517 507 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Bird </sup>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
We examined gene expression in the cerebellum of two different Mecp2-mutant mouse models. The Mecp2tm1.1Jae (J-allele) mutant has an in-frame deletion of exon 3 that codes for half of the MBD [30] (Figure 1A). Therefore, the expected mutant protein, if present, would be unable to bind methylated DNA. In contrast, the sequences encoding the transcriptional-repression domain (TRD), nuclear localization signals and C-terminal WW-binding domain, all encoded by exon 4, are retained. The second mutant, Mecp2tm1.1Bird (B-allele), is deleted for exon 3 and the coding sequence of exon 4 [31]. In this allele, ~ 97% of the Mecp2-coding sequence is deleted, as well as a small part of the 3'UTR. No mutant mRNA was detected on Northern blot [31].
###end p 45
###begin p 46
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Structure and expression of <italic>Mecp2 </italic>mutant alleles</bold>
###xml 53 74 53 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Genomic structure of </italic>
###xml 80 89 80 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mutations</italic>
###xml 50 90 50 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. <italic>Genomic structure of </italic>Mecp2 <italic>mutations</italic>.</bold>
###xml 90 94 90 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink"> a. </bold>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 439 442 439 442 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b. </bold>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 451 460 451 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Jae </sup>
###xml 548 551 548 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c. </bold>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 563 573 563 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Bird </sup>
###xml 726 729 726 729 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 729 771 729 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Real-time quantitative RT-PCR analysis of </italic>
###xml 729 771 729 771 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Real-time quantitative RT-PCR analysis of </italic></bold>
###xml 771 776 771 776 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</bold>
###xml 776 801 776 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> expression in cerebellum</italic>
###xml 776 803 776 803 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic> expression in cerebellum</italic>. </bold>
###xml 844 850 844 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 1055 1061 1055 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 1154 1156 1154 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 1026 1030 <span type="species:ncbi:10090">mice</span>
Structure and expression of Mecp2 mutant alleles. A. Genomic structure of Mecp2 mutations. a. Wild-type Mecp2 gene. MBD, methyl-CpG binding domain; TRD, transcription repression domain. White or hatched: coding sequence. Grey: non-coding parts of transcript. Exons 1 and 2 that are alternatively spliced, and intron 2, are not drawn to scale. Horizontal bar above exon 4 denotes location of the amplicon analyzed by qRT-PCR (in Figure 1B) b. The Mecp2tm1.1Jae (J-allele) mutant has a deletion of exon 3 that encodes the N-terminal half of the MBD. c. In the Mecp2tm1.1Bird (B-allele) mutant, exon 3, the coding portion of exon 4 and part of the 3'UTR are deleted. This larger deletion eliminates ~ 97% of the coding sequence. B. Real-time quantitative RT-PCR analysis of Mecp2 expression in cerebellum. Using primers within the deleted region, Mecp2 transcript was undetectable in mutant mice with the B-allele, when four wild-type and four mutant samples were compared at 8 wk. This proves the specificity of the primers. In mice with the J-allele, mean Mecp2 expression was higher in the mutants, but this difference was not statistically significant (P = 0.11), when six wild-type and seven mutant samples were compared at 8 wk.
###end p 46
###begin p 47
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
Asymptomatic females, heterozygous for a Mecp2 mutation and less than 6 months old, were bred to wild-type males. Offspring were genotyped for Mecp2 and Sry (for sexing). Cerebellar RNA was extracted from hemizygous males at mean ages of 2 wk, 4 wk and 8 wk. At 4 wk, 22% of mutant B-allele mice but none of the J-allele mice were symptomatic. Differences in body weight were observed in both sets of mice beginning at 4 wk, with the mutants being significantly smaller than wild-type littermates. At the "8 wk" time point, 80% of B-allele mice were symptomatic, while the range for J-allele mice extended from 10% at 7 wk to 71% at 9 wk. The most consistent abnormality observed in mutant mice was decreased mobility. At later stages, they developed tremors and hind-limb clasping and appeared poorly groomed.
###end p 47
###begin p 48
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 258 268 258 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Bird </sup>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 319 328 319 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Jae </sup>
###xml 486 487 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
Primers designed to amplify a region of exon 4 did not detect Mecp2 transcripts in B-allele mice as expected, but qRT-PCR studies revealed normal levels of the mutant Mecp2 transcript in 8 wk old mice with the J-allele (Figure 1B). Therefore, while the Mecp2tm1.1Bird B-allele represents a true null mutation, the Mecp2tm1.1Jae (J-allele) produces a stable mutant mRNA capable of directing synthesis of an internally deleted mutant protein that may have retained functions unrelated to mCpG binding. By using whole brain extracts for Western blot analyses, we were unable to detect the predicted protein product of 309 amino acids made from the J-allele. All antibodies we tested cross-reacted with an ~ 55 kD unknown protein in all samples and, therefore, the putative J-allele product may have been obscured. Alternatively, it may have been degraded in the majority of neurons.
###end p 48
###begin title 49
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Differentially expressed genes in Mecp2-mutant mice
###end title 49
###begin p 50
###xml 742 743 742 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 873 874 873 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
To discover gene expression differences between mutant and wild-type cerebella, we performed microarray experiments of both mutant strains under the same conditions. Our microarrays contained 26,000 different cDNA clones spotted on glass slides (Stanford Functional Genomics Facility). Reverse-transcribed cDNA samples from either wild-type or mutant cerebella were hybridized to a cDNA microarray together with a reference sample consisting of pooled cerebellum cDNA. By carrying out hierarchical clustering of the microarray data, we found that several parameters greatly influenced the clustering. In comparing expression data from B-allele mice at 8 wk of age, littermates tended to cluster more than mutants of different litters (Figure 2). Clustering data from only the wild-type control mice illustrate the effects of age, strain background, and array batch (Figure 3). Therefore, in the final analysis, we only compared mutant expression arrays to wild-type arrays of mice that were from the same litter and only microarrays from the same batch. Pair-wise t-tests were performed to combine data from different wild-type/mutant pairs.
###end p 50
###begin p 51
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hierarchical clustering of microarray data from six mutant/wildtype sib pairs</bold>
Hierarchical clustering of microarray data from six mutant/wildtype sib pairs. Male B-allele mutants at 8 wk of age, when most of them are symptomatic, tended to cluster with their wt sibs rather than with mutants of other litters. Litters are identified by A - F. The array of the litter B wild-type sib did not pass quality control standards.
###end p 51
###begin p 52
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hierarchical cluster analysis of microarray data from wild-type sibs at three different ages</bold>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
Hierarchical cluster analysis of microarray data from wild-type sibs at three different ages. Strain background had the greatest influence on clustering. BALB/c is the major background of the J-allele mice, while B-allele mice are on a C57BL/6 background. The effects of array batch, and to a lesser extent, age, are also apparent. We, therefore, compared only microarrays from littermates, at the same age and using the same array batch, in our search for differentially expressed genes.
###end p 52
###begin p 53
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
Consistent with previous expression microarray studies of whole brain or other brain regions, we found that loss of MeCP2 function does not lead to global mis-regulation of gene expression in cerebellum. Even without correction for multiple testing, the total number of differentially expressed genes with a p-value of < 0.05 was not significantly greater than would be expected by chance (Table 1). In B-allele mice, the number of genes with increased expression was slightly greater than would be expected by chance, but only at the 8 wk time point when more of the mutant mice used were symptomatic. The majority of changes reflect an increase of transcript levels, consistent with a relaxation of gene repression.
###end p 53
###begin p 54
Cerebellum gene expression microarray data
###end p 54
###begin p 55
###xml 158 160 158 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
*DEG: Differentially expressed genes with at least a 1.2 fold increase or decrease that are consistently changed for the given mutant and wild-type siblings (P < 0.05).
###end p 55
###begin p 56
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 592 596 592 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tep1</italic>
###xml 692 696 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tep1</italic>
###xml 771 783 771 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tetrahymena </italic>
###xml 1051 1053 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1252 1254 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1361 1366 1361 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tep1 </italic>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 817 823 <span type="species:ncbi:9606">humans</span>
###xml 1417 1421 <span type="species:ncbi:10090">mice</span>
To identify genes of potential biological significance, we studied the datasets from different time points and different alleles for common differentially expressed genes (DEG), but very few consistent differences were detected. The degree of overlap at 2 wk, 4 wk, and 8 wk for each mutant Mecp2 allele is very small (Figure 4A, Additional file 1). In male mice with the J-allele, no genes showed altered expression at all three time points. In B-allele mice, only one Riken clone (H3142G05) [35] was differentially expressed at all time points. Expression of this gene, later identified as Tep1, was increased on microarrays: 1.24, 1.52, and 1.25 fold at 2 wk, 4 wk and 8 wk, respectively. Tep1, which codes for telomerase-associated protein 1, was first discovered in Tetrahymena and is conserved from ciliates to humans. TEP1 is the RNA-binding protein of the telomerase ribonucleoprotein complex that also contains the catalytic reverse transcriptase subunit and an RNA component that serves as a template for the synthesis of telomeric repeats [41]. More recently, TEP1 was also identified as a protein component of vaults that are ribonucleoprotein complexes localized in the cytoplasm of cholinergic nerve terminals close to synaptic vesicles [42]. Specifically, TEP1 is required for the stable association of the vault RNA with the vault complex [43]. Tep1 expression was not significantly changed in mutant mice with the J-allele.
###end p 56
###begin p 57
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Differentially expressed genes (DEG) in cerebellum microarray study</bold>
###xml 72 122 72 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Overlap of DEG at 2 wk, 4 wk, and 8 wk time points</italic>
###xml 69 122 69 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. <italic>Overlap of DEG at 2 wk, 4 wk, and 8 wk time points</italic></bold>
###xml 252 254 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 346 349 346 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 349 411 349 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Overlap of DEG across both mutant alleles at three time points</italic>
###xml 349 413 349 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Overlap of DEG across both mutant alleles at three time points</italic>. </bold>
###xml 461 464 461 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 464 517 464 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Overlap of DEG across all ages in both mutant strains</italic>
###xml 464 517 464 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Overlap of DEG across all ages in both mutant strains</italic></bold>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Differentially expressed genes (DEG) in cerebellum microarray study. A. Overlap of DEG at 2 wk, 4 wk, and 8 wk time points. For both mutant alleles, genes whose transcripts were either increased (1.2-fold or higher) or decreased (0.8-fold or lower) at P < 0.05 are included. Transcripts in the overlap regions are described in Additional file 1. B. Overlap of DEG across both mutant alleles at three time points. The same criteria as in Figure 4A were applied. C. Overlap of DEG across all ages in both mutant strains. The 39 transcripts include the 15 overlapping DEG from Figure 4B as well as genes that were significantly changed at one age in one mutant and at another time point in the other mutant. The list is provided in the Additional file 1.
###end p 57
###begin p 58
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 207 232 207 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 (Gene-trap locus 2) </italic>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 614 627 614 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Delta-like 1 </italic>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlk1</italic>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlk1 </italic>
###xml 740 745 <span type="species:ncbi:10090">mouse</span>
A total of 27 genes were differentially expressed at two different time points, four in the J-allele mutants and 23 in the B-allele mutants (Figure 4A). The gene displaying the greatest expression change is Gtl2 (Gene-trap locus 2) that was up-regulated 1.6 fold at 2 wk and 1.7 fold at 8 wk in B-allele mutants. Increased RNA levels were detected by two different clones on the cDNA microarrays at 2 wk (2210008A22) and 8 wk (1110014G20). The sequences are non-overlapping, but both represent the Gtl2 locus. Gtl2 is an imprinted gene producing a non-coding RNA of unknown function. The paternally expressed gene Delta-like 1 (Dlk1) and the maternally expressed Gtl2 gene are close to each other within an imprinted gene cluster on distal mouse chromosome 12 [44]. Dlk1 expression was not significantly changed in either mutant.
###end p 58
###begin p 59
###xml 157 165 157 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">between </italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Smarcb1</italic>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Satb1</italic>
###xml 495 501 495 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fubp3 </italic>
###xml 505 519 505 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Abt1. Smarcb1 </italic>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1050 1056 1050 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Satb1 </italic>
###xml 1196 1202 1196 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Satb2 </italic>
###xml 1203 1205 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1375 1377 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1479 1485 1479 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fubp3 </italic>
###xml 1489 1493 1489 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Abt1</italic>
###xml 1549 1555 1549 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rab8a </italic>
###xml 1559 1564 1559 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prdm4</italic>
###xml 1614 1615 1614 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1128 1133 <span type="species:ncbi:10090">mouse</span>
###xml 1294 1299 <span type="species:ncbi:9606">human</span>
###xml 1316 1323 <span type="species:ncbi:9031">chicken</span>
###xml 1395 1400 <span type="species:ncbi:10090">mouse</span>
Since any expression changes that are relevant for the phenotype might be seen in both mutant strains, we determined the number of common expression changes between the two strains. In general, there is a low degree of overlap (39 out of 3285 genes) between DEGs in the B- and J-allele mutants, and only 15 genes overlap at the same time points (Figure 4B, Additional file 1). Potentially functionally relevant expression changes were observed in both mutants for several genes: Smarcb1, Satb1, Fubp3 and Abt1. Smarcb1 is a component of the SWI/SNF ATP-dependent chromatin-remodeling complex. Two studies have linked MeCP2 and the SWI/SNF chromatin-remodeling complex [5,45], although this connection is controversial [46]. SATB1 (special AT-rich sequence binding protein 1) is predominantly expressed in thymocytes and specifically binds to nuclear matrix attachment regions (MARs) [47]. It is involved in chromatin loop formation [48] and mediates formation of a higher-order transcriptionally active chromatin structure in activated T cells [49]. Satb1 is also expressed in spinal cord and distinct regions of the developing mouse brain in a mutually exclusive fashion with its close relative Satb2 [50]. Like SATB1, MeCP2 also binds to nuclear matrix-associated DNA repeat sequences in the human genome, and the chicken ortholog of MeCP2 is the MAR-binding protein ARBP [51]. In both mutant mouse models, increased expression was observed for two transcriptional activators, Fubp3 and Abt1, at 8 wk and for two other transcriptional regulators, Rab8a and Prdm4, at 8 wk and 2 wk, respectively (Additional file 1).
###end p 59
###begin title 60
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1</italic>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1</italic>
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln</italic>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Increased expression of Irak1, Fxyd1, Reln, and Gtl2 in Mecp2-mutant mice
###end title 60
###begin p 61
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1</italic>
###xml 166 188 166 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1, Reln, and Gtl2 </italic>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1</italic>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 573 579 573 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 855 861 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
For further studies, we selected four genes based on a fold change of at least 1.4 and consistency in the directional change over the majority of microarrays: Irak1, Fxyd1, Reln, and Gtl2 (Table 2). Expression of Irak1, encoding interleukin-1 receptor-associated kinase 1, was increased in all mutant/wild-type comparisons at 8 wk in B-allele mice. In real-time qRT-PCR experiments, Irak1 expression was increased 3.5-fold in the mutant relative to the wild-type 8 wk B-allele cerebellum samples and 1.9-fold in the forebrain (RC and RF, Figure 5). In the microarray data, Irak1 expression was not significantly altered at other ages, nor was it altered in J-allele mice. The Irak1 gene is located only 3 kb distal to Mecp2. Therefore, this expression change may reflect the altered genomic environment. For example, an element that negatively influences Irak1 expression could be deleted in the B-allele, but not in the J-allele that has a much smaller deletion.
###end p 61
###begin p 62
Genes with increased expression levels on microarrays in B-allele mutants, supported by qRT-PCR and/or ChIP Data
###end p 62
###begin p 63
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Microarray and qRT-PCR results for select DEGs. </bold>
###xml 48 67 48 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1, Fxyd1, Reln </italic>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 307 320 307 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1, Fxyd1 </italic>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 508 510 508 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 541 543 541 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 655 657 655 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 718 720 718 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 834 836 834 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 874 880 874 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 929 931 929 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 984 985 984 985 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(</bold>
###xml 985 987 985 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1099 1101 1099 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1109 1114 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 1177 1179 1177 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1229 1231 1229 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1337 1342 1337 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 1416 1421 1416 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 1460 1465 1460 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 1509 1511 1509 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
Microarray and qRT-PCR results for select DEGs. Irak1, Fxyd1, Reln and Gtl2 were selected for validation of expression changes by qRT-PCR analyses in B-allele mice. Cerebellum microarray expression data (M) are compared with qRT-PCR data from cerebellum (RC), forebrain (RF) and hippocampus (RH). For RC of Irak1, Fxyd1 and Gtl2, the 8 wk samples from the microarray analysis were used. RC2 data are derived from an independent set of litters at 7.5 to 8 wk. Error bars represent SEM. One asterisk indicates P < 0.05, two asterisks indicate P < 0.001. Irak1 expression was markedly increased in the cerebellum of 8 wk B-allele mice on microarray (2-fold, P = 0.011, four mutant/wild-type pairs) and qRT-PCR (3.5 fold, P < 0.001, four mutant/wild-type pairs) as well as in the forebrain of a different set of mice at 7.5 wk (1.9 fold, P < 0.05, three mutant/five wild-type). Fxyd1 expression was elevated 1.4-fold on microarrays (P < 0.05, five mutant/wild-type sibs) and qRT-PCR (RC) (P = 0.053, four mutant/wild-type sibs). The RC2 data (five mutant/three wild-type) were more variable and yielded P = 0.16. Reln displayed an ~ 1.5 fold increase in expression on microarrays (P = 0.03, four mutant/wild-type pairs) and qRT-PCR (P = 0.06, five mutant/wild-type pairs) at 2 wk (RC) and was not changed in hippocampus (RH). On microarray, Gtl2 expression was increased at 8 wk, but by qRT-PCR we found highly variable Gtl2 expression in cerebellum (RC and RC2). Gtl2 expression was not significantly increased (P = 0.29, eight mutant/eight wild-type) in the forebrain.
###end p 63
###begin p 64
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 510 516 510 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 637 643 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
Fxyd1 encodes the FXYD domain containing ion transport regulator 1, also called phospholemman. Fxyd1 expression was consistently increased in all microarray experiments (average 1.4 fold) of B-allele mice at 8 wk (Table 2). The results were confirmed by qRT-PCR analysis on the same cerebellum samples (RC, Figure 5). Biological replication by qRT-PCR on a different set of B-allele mice (RC2; 3 wt, 5 mut) yielded more variable results between litters resulting in large SEM error bars and a p-value of 0.13. Fxyd1 expression in forebain samples from six different litters showed no difference between mutant and wild-type samples, but Fxyd1 expression is normally very low in forebrain.
###end p 64
###begin p 65
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
Reln, encoding the extracellular signaling molecule reelin, is highly expressed in the developing cerebellum. Reelin is essential for proper neuronal lamination and synaptic plasticity. We found increased Reln transcript levels (1.5 fold) in four microarray experiments of B-allele samples at 2 wk (M, Figure 5). Reln expression was also increased in qRT-PCR experiments (RC), but this increase is not statistically significant as there was substantial variation among the samples tested (Figure 3). No difference was seen in hippocampus when 5 wild-type and 7 mutant samples were compared (RH, Figure 5).
###end p 65
###begin p 66
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEG3</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 131 137 <span type="species:ncbi:9606">humans</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
Gtl2, encoding an imprinted maternally expressed non-translated RNA, is the mouse homolog of MEG3, maternally expressed gene 3, in humans. A study evaluating the transcripts encoded by Gtl2 identified 13 different splice variants [52]. Our microarray data revealed significantly increased Gtl2 expression at 2 wk and 8 wk in B-allele mice (M, Figure 5). By qRT-PCR assays, the expression increase was present, but not significant in the same samples (RC) and in forebrain (RF, Figure 5). Cerebellum studies of a new set of mice (3 wt, 5 mut), however, showed no difference (RC2, Figure 5).
###end p 66
###begin title 67
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 104 116 104 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 in vivo</italic>
MeCP2 binds to the promoters of Fxyd1 and Reln and the promoter and differentially-methylated region of Gtl2 in vivo
###end title 67
###begin p 68
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
To determine if MeCP2 binds directly to the potential target genes, we performed chromatin immunoprecipitation (ChIP) assays on brain tissues. ChIP involves cross-linking genomic DNA to proteins that are bound to it. Subsequently, DNA-protein complexes are isolated by immunoprecipitation with a MeCP2 antibody and cross-links are reversed. The MeCP2 bound sequences are used as templates for semi-quantitative PCR to determine whether the gene region of interest is binding to MeCP2 [40].
###end p 68
###begin p 69
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 680 689 680 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Bird</sup>
###xml 389 394 <span type="species:ncbi:10090">mouse</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
When we used primers specific for the 500-1000 bp Fxyd1 or Reln promoter regions, ChIP results indicated specific MeCP2 interaction in normal brain extracts (Figure 6). Amplification was enriched only in the presence of MeCP2 antibody (Figure 6, lanes 4). There was no, or much less, amplification of the DNA fragments when ChIP was performed either with nuclear extract from Mecp2-mutant mouse brain (lanes 1), or without MeCP2 specific antibody (lanes 2), or with non-specific antibody (IgG) (lanes 3). The results suggest that MeCP2 is part of a complex that is located at the promoter regions of these genes in normal brain and that this complex may not form in brain of Mecp2tm1.1Bird mutant mice.
###end p 69
###begin p 70
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chromatin immunoprecipitation (ChIP) analysis of differentially expressed genes</bold>
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 589 595 589 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln</italic>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 855 862 855 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 391 397 <span type="species:ncbi:9986">rabbit</span>
Chromatin immunoprecipitation (ChIP) analysis of differentially expressed genes. Whole brain nuclear extracts from 4 wk old wild-type and B-allele mutants were used for ChIP. Lane M, 100 bp ladder; lane 1, Mecp2-mutant chromatin precipitated with anti-MeCP2 (negative control); lane 2, wild-type chromatin precipitated with no antibody present; lane 3, wild-type chromatin precipitated with rabbit IgG, lane 4: wild-type chromatin precipitated with anti-MeCP2, lane 5: input DNA, lane 6: no DNA control. The precipitated DNA was amplified with primers specific for the promoter regions of Fxyd1 and Reln, and for the promoter/DMR of Gtl2. The Gtl2-B amplicon is located within the Gtl2-A amplicon. Precipitation with anti-MeCP2 shows enrichment relative to the IgG and no antibody controls, indicating that MeCP2 is associated with the designated regions in vivo. As negative controls, PCR was performed using primers covering regions that do not interact with MeCP2 for each ChIP reaction (not shown).
###end p 70
###begin p 71
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
Gtl2 is an imprinted transcript whose maternal-specific expression is controlled by a differentially-methylated region (DMR) that overlaps the promoter region. MeCP2 binding was systematically analyzed using overlapping primer sets, each of which covers 250-400 bp of a region that contains the Gtl2-DMR (AJ320506, nt 92340-95350). MeCP2 binding activity was detected upstream of exon 1 and extending through exon 1 into intron 1 (AJ320506, 93720-95350) (Figure 6). This 1.6 kb region contains 63 CpG dinucleotides, many of which are differentially methylated.
###end p 71
###begin title 72
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
FXYD1 expression in human brain with MeCP2 deficiency
###end title 72
###begin p 73
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 268 274 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 506 512 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 657 663 657 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 684 690 684 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS18 </italic>
###xml 891 897 891 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 988 994 988 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 1098 1104 1098 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 1192 1197 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 1251 1257 1251 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
###xml 402 407 <span type="species:ncbi:9606">human</span>
###xml 1152 1158 <span type="species:ncbi:9606">humans</span>
###xml 1205 1209 <span type="species:ncbi:10090">mice</span>
Recently, Deng et al (2007) [53] identified FXYD1 as a target of MeCP2 by increased expression in the frontal cortex of RTT individuals and of Mecp2-mutant mice, with no changes observed in the cerebellum. While these authors confirmed by ChIP that MeCP2 binds to the FXYD1 promoter, their expression results were the opposite of our findings in mouse brain. Therefore, we examined FXYD1 expression in human brain samples from five RTT females, two males with congenital encephalopathy (CE) and documented MECP2 mutations, and seven non-RTT controls (Figure 7). We used real-time quantitative RT-PCR with the same primers as Deng et al. [53]. We normalized FXYD1 expression levels to RPS18 expression rather than to rRNA expression. The ages of the donors differed only slightly, with controls in their 30 s and RTT females in their 20 s. The two CE males were between 1 and 2 years old. No MECP2 mutation had been identified in the single female RTT sample (UMB# 1748) with an increased FXYD1 transcript, but a brain contusion lesion was seen on autopsy. Our results do not confirm an increase in FXYD1 expression in frontal cortex of MeCP2-deficient humans, and they agree with our data on Mecp2-mutant mice. If MeCP2 were responsible for silencing FXYD1 in the forebrain, one would expect to observe a major increase in hemizygous males with CE who have no MeCP2 activity at all, as compared to RTT females who are mosaic for MeCP2-deficient and normal cells.
###end p 73
###begin p 74
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relative <italic>FXYD1 </italic>expression in human frontal cortex</bold>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2</italic>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1 </italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS18</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
Relative FXYD1 expression in human frontal cortex. Quantitative real-time RT-PCR analyses were carried out on frozen frontal cortex samples from seven unaffected controls (C1 - C7), two MECP2-mutant males with congenital encephalopathy (CE) and five females diagnosed with RTT, with or without identified MECP2 mutations. The mutant samples are identified by their brain bank numbers. FXYD1 expression was normalized to RPS18, a constitutive ribosomal protein gene that is expressed at a similar level in brain. To calculate relative fold changes, control sample C4 was arbitrarily set at 1. All samples were run in triplicate on the same plate.
###end p 74
###begin title 75
Discussion
###end title 75
###begin p 76
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 695 705 695 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Bird </sup>
###xml 720 725 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 725 734 725 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1.1Jae </sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 636 641 <span type="species:ncbi:10090">mouse</span>
The aim to discover abnormally expressed genes in MeCP2-deficient mice is two-fold: to reveal direct targets of MeCP2 modulation and to identify components of neuronal pathways and circuits that are deregulated in affected brain regions. The ultimate goals are to understand the pathophysiologic processes that lead to morbidity in RTT and to design rational therapies to prevent or revert the functional abnormalities. To reduce microarray data noise caused by cellular heterogeneity of tissues, we focused on the cerebellum, a part of the brain not previously studied. We compared expression profiles in two different MeCP2-deficient mouse strains that differ on the molecular level, the Mecp2tm1.1Bird (B-allele) and Mecp2tm1.1Jae (J-allele). Furthermore, we compared expression profiles at three postnatal ages that span different developmental stages in the cerebellum. At two weeks, granule cells are still mitotic and migrating to their final position in the internal granule layer. At four and eight weeks, granule cells are post-mitotic and have begun forming synapses with neurons in the cerebellum and other brain regions.
###end p 76
###begin p 77
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
Consistent with previous studies on forebrain and hippocampus samples by Tudor and colleagues [23], we did not observe major expression changes of a large number of genes in the cerebellum. MeCP2-deficiency does not significantly alter the cerebellar transcriptome on a global scale. This is remarkable given that the vast majority of cells in the cerebellum are granule cells that had shown morphological abnormalities in J-allele mice [30]. Any significant overexpression of genes specifically in granule cells should have been detectable, as it would not be averaged out by cell type heterogeneity. Our results should caution investigators who engage in cell-type specific profiling studies. Also, no large (> 3 fold) changes were detected for any single gene. The changes in cerebellum transcript levels tended to be small (1.5 - 2 fold), but increases greatly outnumbered decreases. Overall, a number of genes with increased transcript levels greater than expected by chance were observed only in B-allele mice at 8 wk. There are several possible explanations for these findings.
###end p 77
###begin p 78
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1151 1156 1151 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 1230 1232 1230 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 1203 1207 <span type="species:ncbi:10090">mice</span>
###xml 1318 1322 <span type="species:ncbi:10090">mice</span>
###xml 1358 1362 <span type="species:ncbi:10090">mice</span>
First, the mutations are different. While B-allele mice are null at the Mecp2 locus, the J-allele mutation consists of an in-frame deletion of exon 3 that produces a stable mutant transcript. The putative mutant protein, which lacks the MBD domain, but has an intact nuclear localization signal, transcription repression domain and C-terminal region, may have maintained certain functions. Some evidence has been reported for a truncated MeCP2 protein in the J allele mice. Luikenhuis et al. [54], saw diffuse nuclear staining with a MeCP2 antibody and speculated that this probably arose from the detection of the truncated protein. This interpretation is in line with the original report of the J-allele mice [30], where Western blot showed a smaller band that was interpreted to represent the truncated protein, even though the wild-type samples had a protein of apparently the same size, but at a lower level of intensity. The possibility cannot be excluded, however, that the diffuse nuclear staining was caused by a cross-reacting protein that does not localize to DAPI-positive foci. Using tissue microarrays to study the mosaic composition of Mecp2-expressing and non-expressing cells in female mice, Braunschweig et al. [55], reported a background immunoreactivity with a C-terminal antibody in male J-allele mice that was apparently not present in mice with the B-allele. These results would argue in favor of the presence of an internally deleted mutant protein present in the J-allele brain, although the intensity was rather low.
###end p 78
###begin p 79
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Second, the mice were on different strain backgrounds: B-allele mice on C57BL/6 and J-allele mice on a mixed background, mostly BALB/cJ. Our hierarchical clustering data clearly demonstrated a strong effect of strain background (Figure 3). Random mixed strain background noise should be overcome, to some extent, by our comparing only wild-type and mutant sib-pairs and by including a sufficiently large number of sib-pairs (16 for the B-allele and 13 for the J allele).
###end p 79
###begin p 80
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Third, 80% of the B-allele mice at 8 wk were symptomatic, while fewer of the J-allele mice were showing symptoms. When the disease process in the brain is further advanced, the expression changes may be caused by pathologic events far downstream of direct MeCP2 action.
###end p 80
###begin p 81
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1</italic>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1</italic>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln</italic>
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 623 629 623 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 717 722 <span type="species:ncbi:10090">mouse</span>
Although the global level of gene expression is not significantly altered, that does not preclude the possibility that some of the genes may have changed expression levels that are biologically relevant. Therefore, we focused on whether differentially expressed genes showed a similar change in other brain regions and in a different set of mice (biological validation), which is a more relevant evaluation than "statistical" validation. We chose four genes, Irak1, Fxyd1, Reln, and Gtl2, whose expression levels were increased in the most consistent fashion. By ChIP analyses, we show that MeCP2 binds to the promoters of Fxyd1 and Reln and to a differentially methylated region of the imprinted gene Gtl2 in normal mouse brain, suggesting that these genes may be direct targets of MeCP2.
###end p 81
###begin title 82
Irak1
###end title 82
###begin p 83
###xml 244 250 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 413 419 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 536 542 536 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 630 636 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 720 726 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1</italic>
###xml 990 1000 990 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 1254 1260 1254 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
The interleukin-1 receptor-associated kinase 1 gene revealed the largest significant expression increase of any gene, in cerebellum (2.0-fold on microarray and 3.5-fold on qRT-PCR assays) and in forebrain (1.9-fold), but only in B-allele mice. Irak1 is located ~ 3 kb downstream of Mecp2 in the same transcriptional orientation (UCSC Genome browser, Feb 2006 assembly). This suggests that a negative regulator of Irak1 could have been lost with the B-allele deletion, or that the altered local chromatin conformation leads to increased Irak1 expression. The less likely possibility that MeCP2 directly regulates the expression of Irak1 would assume that the J-allele has maintained a negative regulatory function, since Irak1 expression is not increased in J-allele mutants. This allele-specific difference raises the concern that the increased Irak1 expression may be responsible for some dysregulated genes in the B-allele mice that are not dysregulated in the J-allele mice. To identify bona fide MeCP2 targets we, therefore, focused on genes whose promoters bind MeCP2 in ChIP assays. Nevertheless, any studies done with the B-allele mice, at any level, from behavior to histology, should be considered in the light of possible downstream effects of Irak1 overexpression.
###end p 83
###begin p 84
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pelle </italic>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1 </italic>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 404 410 <span type="species:ncbi:9606">humans</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
IRAK1 belongs to the ser/thr protein kinase family, pelle subfamily. The protein is comprised of a death domain in the N-terminus, a central serine/threonine kinase domain, and a C-terminal serine/threonine rich region. Once phosphorylated, IRAK1 recruits the adapter protein PELI1 and causes activation of Toll-like-receptor-mediated intracellular signaling pathways. Three different splice variants in humans and mice differ in their relative abundance in brain, and differential splicing of IRAK1 may correlate with the aging process [56]. Our qRT-PCR assay amplified all three splice forms. Given the postulated role of MeCP2 in alternative splicing [11], it might be of interest to evaluate the relative abundance of the different Irak1 splice forms in Mecp2-mutant B-allele brain.
###end p 84
###begin title 85
Fxyd1
###end title 85
###begin p 86
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 358 364 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 400 406 400 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 703 709 703 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYXD1 </italic>
###xml 776 782 776 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MECP2 </italic>
###xml 993 998 993 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYXD1</italic>
###xml 999 1005 999 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 1189 1191 1189 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 663 669 <span type="species:ncbi:9606">humans</span>
###xml 909 915 <span type="species:ncbi:9606">humans</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
In wild-type mice, Fxyd1 expression increases drastically from 2 wk to 8 wk in the cerebellum (our microarray data). In Mecp2 mutant mice, microarray and qRT-PCR studies revealed a significant increase of Fxyd1 transcripts at the 8 wk time point in B-allele mutants when compared to wild-type littermates. ChIP analyses confirmed the binding of MeCP2 to the Fxyd1 promoter. We, thus, have identified Fxyd1 as a validated target of MeCP2 binding. In contrast to a recent report by Deng et al. [53], however, Fxyd1 transcripts were not increased in the mutant forebrain where expression levels are normally very low. Attempting to replicate the reported studies in humans, we have used qRT-PCR to measure FYXD1 expression in frontal cortex from male and female individuals with MECP2 mutations and unaffected controls. We found no evidence for increased expression in the mutant samples. Therefore, our data in humans and mice do not support the hypothesis that MeCP2 is responsible for keeping FYXD1/Fxyd1 expression low in the majority of cells of forebrain. A small increase of expression in a neuronal subtype could have gone undetected, but the large increases reported by Deng et al. [53] in RTT frontal cortex are not confirmed by our results.
###end p 86
###begin p 87
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1054 1060 1054 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1120 1126 1120 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fxyd1 </italic>
###xml 1153 1158 1153 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
###xml 1178 1184 <span type="species:ncbi:9606">humans</span>
The protein product, FXYD1, also called phospholemman (PLM), is a small molecule with a single transmembrane domain and a member of the FXYD family of small ion transport regulators. FXYD proteins regulate Na-K-ATPase activity in a tissue- and isoform-specific way. Each FXYD gene is expressed in one or more specific tissues [57]. FXYD1 is a major membrane phosphoprotein in heart and muscle. In brain, FXYD1 is predominantly found in the cerebellum, specifically in the molecular layer, in Purkinje neurons, and in axons traversing the granule cell layer, as well as in the choroid plexus [58]. The protein forms a helical structure and inserts into lipid membranes in a trans-bilayer fashion [59]. FXYD1 tetramers form ion channels selective for K+, Cl-, and taurine that are physically associated with the Na-K-ATPase [60]. Recent studies revealed that FXYD1 also inhibits the cardiac Na+/Ca2+ exchanger (NCX1) [61]. Overexpression of FXYD1 in adult cardiac myocytes acutely alters contractility as a function of extracellular Ca+ concentration, and Fxyd1 knock-out mice have cardiac hypertrophy [62]. Alteration of Fxyd1 expression in the heart of Mecp2-deficient mice and humans could conceivably contribute to cardiac dysfunction and sudden death.
###end p 87
###begin p 88
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sgk1 </italic>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fkbp5 </italic>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 355 359 355 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">308 </sup>
###xml 514 517 514 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crh</italic>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD1</italic>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FXYD4</italic>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
Another member of the FXYD family, FXYD4/CHIF (corticosteroid hormone induced factor) was initially isolated as a glucocorticoid response gene [63]. Interestingly, two putative MeCP2 target genes, Sgk1 and Fkbp5 are also glucocorticoid-inducible and were found to be upregulated in 8 wk old B-allele mice studied previously [25]. Furthermore, in the Mecp2308 mouse model of MeCP2 deficiency, circulating corticosteroid levels were increased in response to stress, and the gene for corticotropin-releasing hormone (Crh) was overexpressed in brain regions, leading to the conclusion that the mutant mice have an enhanced corticosteroid response to stress via increased CRH signaling [64]. Future studies should evaluate whether FXYD1, like FXYD4, is also corticosteroid inducible.
###end p 88
###begin title 89
Reln
###end title 89
###begin p 90
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 759 764 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
Our identification of Reln as a primary target of MeCP2 is supported by the following observations: Reln transcript levels were increased in microarray and qRT-PCR experiments comparing cerebella from a total of 12 wild-type and 9 mutant mice. And the expression change was seen at the earliest time point (2 wk) when all mice were asymptomatic. No expression change was found in hippocampus. ChIP assay on whole brain documented that MeCP2 binds to the Reln promoter in normal mice. The proximal promoter of Reln is highly CpG-rich and methylated in whole brain extracts [65]. Multiple hypermethylation sites at the Reln promoter can be induced by injection of L-methionine. And in a methionine-induced model of schizophrenia, MeCP2 was shown to bind to the Reln promoter [66,67].
###end p 90
###begin p 91
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 530 536 530 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
Reelin is a large extracellular protein that is produced by discrete populations of cells in the brain. It acts through the extracellular milieu on neighboring target cells. Until recently, the primary function of reelin was thought to involve regulation of neuronal migration during fetal brain development, by reelin providing an architectonic signal for the guidance of migrating neurons [68,69]. Reelin-expressing cells include the Cajal-Retzius (CR) cells in the cortical marginal zone, that are the first neurons to express Mecp2 in development, and cerebellar granule cells. MeCP2-deficient mice have a thinner cortex and more densely packed neurons that could result from migratory defects.
###end p 91
###begin p 92
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Src </italic>
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fyn</italic>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
Reln expression continues in the adult, in particular in a subset of GABAergic neurons of the forebrain, as well as in the olfactory bulb [70]. Reelin can modulate synaptic plasticity and enhance long-term potentiation (LTP) in adult hippocampal cultures [71]. The signaling pathway that reelin acts on involves two high-affinity binding receptors, the very low density lipoprotein receptor (VLDLR) and the apolipoprotein E receptor 2 (ApoER2) [72]. Binding of reelin to VLDLR and ApoER2 triggers phosphorylation of the cytoplasmic adaptor protein disabled 1 (Dab1) by Src family kinases, in particular Fyn. This series of reactions is required for cortical layer formation and for hippocampal dendrite development [73]. In addition, cyclin-dependent kinase 5-dependent signals are required for the function of reelin not only in neuronal migration but also in synaptic transmission [74]. The reelin signaling pathway is also involved in modulating learning and behavior [75]. Reelin can regulate NMDA-type glutamate receptor activity and potentiate calcium influx through NMDA receptors in neuronal cultures [75]. Sinagra et al. [76] documented a reelin-controlled change in subunit composition of NMDA glutamate receptors during maturation. Reelin signaling through ApoE receptors plays an essential role in synaptic plasticity and function in the adult brain [77].
###end p 92
###begin p 93
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bdnf </italic>
###xml 285 297 285 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reeler (rl) </italic>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 393 402 393 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
Interestingly, BDNF, brain-derived neurotrophic factor, a primary target of MeCP2 [78,79] regulates reelin production in cortical neurons. Bdnf -/- mice have elevated reelin levels in Cajal-Retzius cells. Overexpression of BDNF produces brain abnormalities similar to the phenotype of reeler (rl) mutant mice. This phenotype is preserved in slice cultures of hippocampus [80]. Furthermore, in in vitro co-culture systems, exogenous reelin caused dispersal of chain-migrating interneuron precursors in the olfactory bulb, suggesting that overexpression of reelin may affect neuronal migration [81].
###end p 93
###begin p 94
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 427 432 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reln </italic>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2 </italic>
###xml 486 488 486 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rl</italic>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 650 655 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 660 663 660 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rln</italic>
###xml 710 715 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rln</italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
We hypothesize that Reln overexpression is responsible for part of the phenotype of MeCP2-deficient mice, and that this phenotype is caused by abnormal neuronal migration in the developing brain of MeCP2-deficient mice and by dysregulation of reelin signaling pathways, thus disturbing synaptic function, in postnatal brain. To test this hypothesis, we have initiated genetic interaction studies. We aim to reduce the level of Reln expression in the Mecp2 mutant background by crossing rl+/- heterozygous males to Mecp2+/- female mice. We have preliminary evidence that the onset of morbid phenotypes is delayed and lifespan prolonged in some of the Mecp2Y/- ;Rln+/- double-mutant mice, when compared to their Mecp2Y/- ;Rln+/+ littermates.
###end p 94
###begin title 95
Gtl2 (gene trap locus 2)
###end title 95
###begin p 96
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEG3 </italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 589 594 589 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 838 843 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 901 906 901 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 89 95 <span type="species:ncbi:9606">humans</span>
###xml 560 565 <span type="species:ncbi:9606">human</span>
###xml 917 921 <span type="species:ncbi:10090">mice</span>
By microarray analysis, we identified Gtl2, called MEG3 (Maternally-expressed gene 3) in humans, as a significantly increased transcript in mutant cerebellum samples. qRT-PCR confirmed increased expression, although not significant due to large biological variation in different litters, in cerebellum and forebrain. Gtl2 encodes a maternally expressed imprinted non-translated RNA of unknown function. Gtl2 is expressed in most tissues, but most highly in brain. It lies within a cluster of imprinted genes on chromosome 12 that is conserved on distal 14q in human. Alternatively-spliced Gtl2 transcripts extend to include intron-encoded C/D box snoRNAs [82] and microRNAs [83,84]. Thus, Gtl2 might function as a host gene for these small RNAs. In our qRT-PCR assays, the increase in Gtl2 expression in cerebellum was less striking, but Gtl2 expression was consistently increased in the forebrain of Mecp2-deficient mice.
###end p 96
###begin p 97
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 341 346 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 899 907 899 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtl2 </italic>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
Two previous studies have identified Gtl2 as a possible target of MeCP2. An expression microarray study on whole brain of one B-allele mouse revealed a 1.9-fold increase in Gtl2 expression [25]. Independently, by using a variant of differential display technology and qRT-PCR confirmation, Kriaucionis and colleagues [27] detected increased Gtl2 expression in whole brains of B-allele mice. Since the increase was significant only at late symptomatic stages, the authors suggested that it may represent a secondary consequence of the disease pathology. In contrast, our data show a similar increase in Gtl2 expression at 2 wk and at 8 wk, albeit detected by two different cDNA clones on the array. Gtl2 has a CpG-rich promoter region that is unmethylated on the maternal allele and becomes hypermethylated on the paternal allele after fertilization [85,86]. By ChIP assay, we found that MeCP2 binds in vivo to this region with binding sites extending from 5' of exon 1 into intron 1, raising the possibility that it may play a role in silencing of the paternal allele. Alternatively, MeCP2 may bind to methylated CpG sites on the active maternal chromosome and thus regulate Gtl2 repression in certain brain regions or cell types. Future studies of allele-specific expression levels will address these possibilities.
###end p 97
###begin p 98
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Snrp70</italic>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Uqcrc1 </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bdnf </italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlx5 </italic>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 436 442 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fkbp5 </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sgk1 </italic>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bdnf </italic>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 926 931 926 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
Considering other previously reported candidate MeCP2 target genes that are represented on our microarrays: Only Snrp70, reported to be increased by qRT-PCR in whole brain from late symptomatic B-allele mice (1.44 fold, p = 0.04)[27], showed increased expression (1.5-fold) in cerebellum of 8 wk B-allele mice in our study. None of the following genes had significant expression changes in cerebellum: Uqcrc1 [27], Bdnf [87], Dlx5 [4], Fkbp5 and Sgk1 [25]. This is not surprising given that some of these genes may be primarily expressed in other brain regions and/or only in certain neuronal sub-types. Or transcript levels may be variable, when expression is modulated by activity state as for Bdnf [78,79]. Our experience with biological validation and hierarchical clustering of independent samples taught us about the mitigating effects of different sibship identities. We need to consider that the different mothers are Mecp2+/- heterozygotes, having the genotype of females with RTT. Although not obviously symptomatic yet, their variable X-inactivation status could influence expression profiles in their offspring.
###end p 98
###begin title 99
Conclusion
###end title 99
###begin p 100
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Irak1</italic>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mecp2</italic>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 642 648 <span type="species:ncbi:9606">humans</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
Cerebellar gene expression profiling of two Mecp2-mutant mouse models at three postnatal time points revealed no significant global changes. Irak1, located close to Mecp2, showed the most significant expression increase, but this may be specific to the large deletion in B-allele mice. We identified three novel direct MeCP2 target genes by increased expression and binding of MeCP2 to their promoters. Variable results in different litters do no preclude the potential importance of these genes. To evaluate the contributions of these mis-regulated genes to the synaptic dysfunction and neuropathologic phenotype observed in MeCP2-deficient humans and mice, further studies using higher cytological resolution, laser-capture dissection and immunohistochemical assays, as well as genetic interaction studies and functional assays of the affected pathways, will be needed.
###end p 100
###begin title 101
List of Abbreviations
###end title 101
###begin p 102
RTT, Rett syndrome; MeCP2, methyl-CpG binding protein 2; DEG, differentially expressed genes; ChIP, chromatin immunoprecipitation
###end p 102
###begin title 103
Competing interests
###end title 103
###begin p 104
The author(s) declare that they have no competing interests.
###end p 104
###begin title 105
Authors' contributions
###end title 105
###begin p 106
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
CJ carried out the microrray and qRT-PCR studies, and the statistical analyses, and drafted the manuscript. HHL carried out the chromatin immunoprecipitation assays, validation studies and qRT-PCR of human brain samples. HCK participated in mouse breeding, genotyping and experimental design. UF conceived of the study, participated in its design, interpreted the results and prepared the final manuscript. All authors read and approved the final manuscript.
###end p 106
###begin title 107
Pre-publication history
###end title 107
###begin p 108
The pre-publication history for this paper can be accessed here:
###end p 108
###begin p 109

###end p 109
###begin title 110
Supplementary Material
###end title 110
###begin title 111
Additional File 1
###end title 111
###begin p 112
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
Differentially expressed genes (DEG) illustrated in Figure 4. This table lists the DEGs in the overlaps shown in Figure 4, their fold changes in B-allele and J-allele mice at different ages and their Clone IDs.
###end p 112
###begin p 113
Click here for file
###end p 113
###begin title 114
Acknowledgements
###end title 114
###begin p 115
###xml 156 163 <span type="species:ncbi:185739">Pollack</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
The authors are grateful to Francke Lab members for helpful discussions and assistance, to Kate Rubins for helping with microarrays, to Craig April and Jon Pollack for advice in designing experiments and analyzing data, to Birgitt Schule for human brain RNA samples, and to Peggy Farnham for advice on ChIP protocols.
###end p 115
###begin p 116
###xml 99 104 <span type="species:ncbi:9606">Human</span>
Funding: C.J. was supported by the Stanford Genome Training Program (T32 HG00044 from the National Human Genome Research Institute). This work was supported in part by research grants from the NIH and the International Rett Syndrome Association.
###end p 116
###begin article-title 117
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA
###end article-title 117
###begin article-title 118
DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG
###end article-title 118
###begin article-title 119
###xml 51 56 <span type="species:ncbi:9606">human</span>
DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells
###end article-title 119
###begin article-title 120
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome
###end article-title 120
###begin article-title 121
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing
###end article-title 121
###begin article-title 122
Methylation-dependent silencing at the H19 imprinting control region by MeCP2
###end article-title 122
###begin article-title 123
Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent
###end article-title 123
###begin article-title 124
###xml 101 106 <span type="species:ncbi:9606">human</span>
Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells
###end article-title 124
###begin article-title 125
###xml 24 29 <span type="species:ncbi:9606">human</span>
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation
###end article-title 125
###begin article-title 126
Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin
###end article-title 126
###begin article-title 127
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2
###end article-title 127
###begin article-title 128
Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation
###end article-title 128
###begin article-title 129
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
###end article-title 129
###begin article-title 130
Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotpots
###end article-title 130
###begin article-title 131
Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett Syndrome
###end article-title 131
###begin article-title 132
Uber ein eigenartiges hirnatrophisches Syndrom bei Hyperammonamie im Kindesalter
###end article-title 132
###begin article-title 133
###xml 87 92 <span type="species:ncbi:9606">girls</span>
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases
###end article-title 133
###begin article-title 134
###xml 18 23 <span type="species:ncbi:9606">girls</span>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Rett syndrome: of girls and mice--lessons for regression in autism
###end article-title 134
###begin article-title 135
Neurogenetics of MeCP2 deficiency
###end article-title 135
###begin article-title 136
###xml 36 40 <span type="species:ncbi:9606">boys</span>
Early progressive encephalopathy in boys and MECP2 mutations
###end article-title 136
###begin article-title 137
###xml 94 101 <span type="species:ncbi:9606">patient</span>
Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification.
###end article-title 137
###begin article-title 138
Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations
###end article-title 138
###begin article-title 139
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain
###end article-title 139
###begin article-title 140
###xml 74 82 <span type="species:ncbi:9606">patients</span>
The impact of MECP2 mutations in the expression patterns of Rett syndrome patients
###end article-title 140
###begin article-title 141
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome
###end article-title 141
###begin article-title 142
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients
###end article-title 142
###begin article-title 143
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome
###end article-title 143
###begin article-title 144
Large-scale gene expression differences across brain regions and inbred strains correlate with a behavioral phenotype
###end article-title 144
###begin article-title 145
Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain
###end article-title 145
###begin article-title 146
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
###end article-title 146
###begin article-title 147
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
###end article-title 147
###begin article-title 148
Rett syndrome: cerebellar pathology
###end article-title 148
###begin article-title 149
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Ube3a expression is not altered in Mecp2 mutant mice
###end article-title 149
###begin article-title 150
Stanford Functional Genomics Facility
###end article-title 150
###begin article-title 151
SOURCE
###end article-title 151
###begin article-title 152
Brown Lab Experimental Protocols
###end article-title 152
###begin article-title 153
Significance analysis of microarrays applied to the ionizing radiation response.
###end article-title 153
###begin article-title 154
Cluster analysis and display of genome-wide expression patterns
###end article-title 154
###begin article-title 155
The Stanford Microarray Database
###end article-title 155
###begin article-title 156
Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins
###end article-title 156
###begin article-title 157
A mammalian telomerase-associated protein
###end article-title 157
###begin article-title 158
Vaults and telomerase share a common subunit, TEP1
###end article-title 158
###begin article-title 159
The Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle
###end article-title 159
###begin article-title 160
The Dlk1 and Gtl2 genes are linked and reciprocally imprinted
###end article-title 160
###begin article-title 161
Histone deacetylase directs the dominant silencing of transcription in chromatin: association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase
###end article-title 161
###begin article-title 162
Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex
###end article-title 162
###begin article-title 163
A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition
###end article-title 163
###begin article-title 164
SATB1 targets chromatin remodelling to regulate genes over long distances
###end article-title 164
###begin article-title 165
SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes
###end article-title 165
###begin article-title 166
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS
###end article-title 166
###begin article-title 167
A matrix/scaffold attachment region binding protein: identification, purification, and mode of binding
###end article-title 167
###begin article-title 168
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Alternative splicing and imprinting control of the Meg3/Gtl2-Dlk1 locus in mouse embryos
###end article-title 168
###begin article-title 169
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
FXYD1 is a MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice
###end article-title 169
###begin article-title 170
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice
###end article-title 170
###begin article-title 171
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain
###end article-title 171
###begin article-title 172
Differential regulation of interleukin-1 receptor associated kinase 1 (IRAK1) splice variants
###end article-title 172
###begin article-title 173
FXYD proteins: new regulators of Na-K-ATPase
###end article-title 173
###begin article-title 174
Phospholemman, a single-span membrane protein, is an accessory protein of Na,K-ATPase in cerebellum and choroid plexus.
###end article-title 174
###begin article-title 175
Secondary structure, orientation, and oligomerization of phospholemman, a cardiac transmembrane protein
###end article-title 175
###begin article-title 176
Role of FXYD proteins in ion transport
###end article-title 176
###begin article-title 177
Identification of an endogenous inhibitor of the cardiac Na+/Ca2+ exchanger, phospholemman
###end article-title 177
###begin article-title 178
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice
###end article-title 178
###begin article-title 179
The corticosteroid hormone induced factor: a new modulator of KCNQ1 channels?
###end article-title 179
###begin article-title 180
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome
###end article-title 180
###begin article-title 181
###xml 36 41 <span type="species:ncbi:9606">human</span>
On the epigenetic regulation of the human reelin promoter
###end article-title 181
###begin article-title 182
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia
###end article-title 182
###begin article-title 183
Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters
###end article-title 183
###begin article-title 184
Reelin and brain development
###end article-title 184
###begin article-title 185
Central nervous system neuronal migration
###end article-title 185
###begin article-title 186
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse
###end article-title 186
###begin article-title 187
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
###end article-title 187
###begin article-title 188
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.
###end article-title 188
###begin article-title 189
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development.
###end article-title 189
###begin article-title 190
Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission.
###end article-title 190
###begin article-title 191
Reelin modulates NMDA receptor activity in cortical neurons
###end article-title 191
###begin article-title 192
Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro
###end article-title 192
###begin article-title 193
Reelin, lipoprotein receptors and synaptic plasticity
###end article-title 193
###begin article-title 194
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2
###end article-title 194
###begin article-title 195
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation
###end article-title 195
###begin article-title 196
Reelin is a positional signal for the lamination of dentate granule cells.
###end article-title 196
###begin article-title 197
Reelin is a detachment signal in tangential chain-migration during postnatal neurogenesis
###end article-title 197
###begin article-title 198
###xml 70 75 <span type="species:ncbi:9606">human</span>
Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region
###end article-title 198
###begin article-title 199
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12
###end article-title 199
###begin article-title 200
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12
###end article-title 200
###begin article-title 201
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q
###end article-title 201
###begin article-title 202
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Delta-like and gtl2 are reciprocally expressed, differentially methylated linked imprinted genes on mouse chromosome 12
###end article-title 202
###begin article-title 203
###xml 40 44 <span type="species:ncbi:10090">mice</span>
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
###end article-title 203
###begin article-title 204
Stanford Microarray Database
###end article-title 204
###begin article-title 205
EBI ArrayExpress
###end article-title 205

